SCHEMBL13601858

SCHEMBL13601858

Cc1cc(-c2nc(-c3ccc(CO)c(CO)c3)no2)c(F)cc1-c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.44
RAB9A P51151 8/20 0.44
NPC1 O15118 7/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
TP53 P04637 3/20 0.44
CA4 P22748 1/20 0.41
MAOA P21397 1/20 0.40
BLVRB P30043 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
S1PR3 Q99500 2/20 0.40
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
GRM5 P41594 2/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601840 0.88 S1PR1 (0.52) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601885 0.87 CA4 (0.52) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601869 0.87 NPC1 (0.46) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601861 0.85 NPC1 (0.52) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601890 0.84 S1PR1 (0.44) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601841 0.83 PTGES (0.51) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601875 0.82 NPC1 (0.42) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601849 0.82 RAB9A (0.49) S1PR1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL13601599 0.81 S1PR1 (0.48) S1PR1RAB9ANPC1SMN1; SMN2HDAC6
SCHEMBL13601881 0.78 ALDH1A1 (0.56) S1PR1RAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298894-A1 AMINO ACID COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2009-12-03 US disclosed
US-20090298894-A1 AMINO ACID COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298894-A1 AMINO ACID COMPOUNDS S1PR1, S1PR2, S1PR5 S1PR1 1/4885RAB9A 3060/4885NPC1 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.